Q32 Bio Inc. (ticker: QTTB) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of QTTB's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. QTTB reported $53.74M in revenue and -$7.61M for the period ending 2025-12-31, with operating cash flow of -$6.34M. Cash and equivalents stood at $50.75M (down 22.5% year-over-year). Total assets of $63.67M exceed total liabilities of $17.36M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
QTTB SEC Filings
Full cached SEC EDGAR filing history for QTTB, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.